Inventor · disambiguated record
Claes Wahlestedt
Also filed as: WAHLESTEDT CLAES · WAHLESTEDT CLAES R
15 granted patents·10 pending applications·165 citations·filing 1996–2024
92Inventor score
Files withUNIV MIAMI4ASTRAZENECA CANADA INC3CA NAT RESEARCH COUNCIL3SANTARIS PHARMA AS2SCRIPPS RESEARCH INST2
Top patents by PatentIndex Score
25 records- 0196US9738894B2Short interfering RNA (siRNA) analoguesROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Aug 22, 2017·55 cites·27 claims
- 0292US8288354B2Natural antisense and non-coding RNA transcripts as drug targetsWAHLESTEDT CLAES·Filed 2006·Granted Oct 16, 2012·33 cites·30 claims
- 0385US6680321B1Compounds with analgesic effectASTRAZENECA CANADA INC·Filed 2000·Granted Jan 20, 2004·20 cites·7 claims
- 0479US6130222ACompounds with analgesic effectASTRA PHARMA INC·Filed 1996·Granted Oct 10, 2000·40 cites·6 claims
- 0575US9297010B2Short interfering RNA (siRNA) analoguesSANTARIS PHARMA AS·Filed 2014·Granted Mar 29, 2016·2 cites·30 claims
- 0674US8653252B2Short interfering RNA (siRNA) analoguesELMEN JOACHIM·Filed 2004·Granted Feb 18, 2014·14 cites·28 claims
- 0770US9803195B2Natural antisense and non-coding RNA transcripts as drug targetsWAHLESTEDT CLAES·Filed 2012·Granted Oct 31, 2017·1 cites·12 claims
- 0869US2024374534A1Methods for treating mucopolysaccharidosisUNIV MIAMI·Filed 2024·Application pending·0 cites
- 0960US12029706B2Methods for treating mucopolysaccharidosisUNIV MIAMI·Filed 2020·Granted Jul 9, 2024·0 cites·13 claims
- 1060US7510846B2Assay employing human or rat GAL-R2 galanin receptorCA NAT RESEARCH COUNCIL·Filed 2006·Granted Mar 31, 2009·0 cites·10 claims
- 1158US10472627B2Natural antisense and non-coding RNA transcripts as drug targetsSCRIPPS RESEARCH INST·Filed 2017·Granted Nov 12, 2019·0 cites·16 claims
- 1253US7407761B2Methods for assaying expression of novel galanin receptorsCA NAT RESEARCH COUNCIL·Filed 2006·Granted Aug 5, 2008·0 cites·7 claims
- 1353US7375207B2Galanin receptor 2 proteins and nucleic acidsCANADA NAT RES COUNCIL·Filed 2006·Granted May 20, 2008·0 cites·12 claims
- 1453US2004138228A1Novel compounds with analgesic effectASTRAZENECA CANADA INC·Filed 2003·Application pending·0 cites
- 1548US2019076376A1Methods for treating mucopolysaccharidosisUNIV MIAMI·Filed 2016·Application pending·0 cites
- 1648US2005064406A1Methods for high throughput genome analysis using restriction site tagged microarraysFiled 2002·Application pending·0 cites
- 1748US2002182616A1Single nucleotide polymorphismsFiled 2001·Application pending·0 cites
- 1846US2005014742A1Use of inhibitors of the y2 receptor of neuropeptide y in the treatment of alcoholismFiled 2002·Application pending·0 cites
- 1944US7528229B2Isolated human and rat GAL-R2 galanin receptorsCA NAT RESEARCH COUNCIL·Filed 2003·Granted May 5, 2009·0 cites·2 claims
- 2043US2002187482A1Methods and means of RNA analysisFiled 2001·Application pending·0 cites
- 2142US9656994B2Substituted benzimidazoles as nociceptin receptor modulatorsSCRIPPS RESEARCH INST·Filed 2014·Granted May 23, 2017·0 cites·6 claims
- 2242US2008249039A1Modified Short Interfering Rna (Modified Sirna)SANTARIS PHARMA AS·Filed 2005·Application pending·0 cites
- 2341US2002119476A1Nucleotide sequences coding for a mammalian coltage-gated potassium channel protein, the amino acid encoded by the nucleic acid and use thereofFiled 2001·Application pending·0 cites
- 2440US2019247302A1Materials and methods for treating ophthalmic inflammationUNIV MIAMI·Filed 2017·Application pending·0 cites
- 2531US6562945B1Galanin receptorASTRAZENECA CANADA INC·Filed 1997·Granted May 13, 2003·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →